Santa Clara, CA – Affymetrix, Inc. (NASDAQ: AFFX) today announced at the American Association for Cancer Research (AACR) 102nd Annual Meeting 2011 in Orlando, Florida, the launch of its second-generation OncoScan™ FFPE Express platform (formerly MIP Copy Number Service). OncoScan™ FFPE Express 2.0offers enhanced coverage of tumor suppressors and oncogenes and provides the same proven […]
Copenhagen, Denmark – Exiqon A/S (NASDAQ OMX: “EXQ”), a leading supplier of research products for qPCR analysis and biomarker development, today announced positive results in the company’s development of a diagnostic test for early detection of colorectal cancer in blood. The results were revealed during an oral presentation at the annual American Association for Cancer […]
WALTHAM, Mass. – Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, has completed the previously announced sales of its two laboratory-testing services businesses, Athena Diagnostics and Lancaster Laboratories, in two separate transactions, resulting in total proceeds of $940 million. Athena Diagnostics has been sold to Quest Diagnostics for $740 million. Based […]
SUNNYVALE, Calif. – Arrayit Corporation (OTCBB: ARYC – News) announces today the product launch of OvaDx®, the market’s first Pre-Symptomatic Screening Test for Ovarian Cancer. The company is offering the first 1,000 tests to attendees of the 102nd annual meeting of the American Association for Cancer Research (AACR) at the Orange County Convention Center in […]
Wiesbaden, Germany — Abbott Molecular announced today that it has received CE Marking (Conformité Européene) to market the Abbott HBV Sequencing test in the European Union. This molecular diagnostic test, developed to identify genomic sequences of the hepatitis B virus (HBV) and help physicians monitor HBV infections, guide treatment decisions, and predict or discover drug […]
Hayward, CA / Munich, Germany – Advanced Cell Diagnostics (ACD), a technological leader in molecular pathology, and Definiens, a leading provider for biomedical image and data analysis, announce today a strategic partnership to develop image analysis applications that will enable researchers to accurately quantify specific RNA molecules within individual cells in routine clinical specimen. The […]
Austin, Texas – Asuragen, Inc. announced today the launch of its new miRNA Biofluids service offering designed to interrogate miRNAs from serum, plasma, cerebral spinal fluid, and urine. Supported by a growing body of literature, the utility of miRNA biomarkers in biofluids has been demonstrated for numerous disease areas including Cancer, Neurology, Autoimmune, and Cardiovascular […]
BRANFORD, Conn. – 454 Life Sciences, a Roche Company, announced today the launch and immediate availability of the new GS GType HLA Primer Sets for high- and medium-resolution genotyping of class I and class II loci of the Human Leukocyte Antigen (HLA) genes. The primer sets are designed for use with the company’s benchtop GS […]
WALTHAM, MA – PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the introduction of a new oncology testing service. The new service utilizes OncoChip™, a new microarray technology to aid in faster, earlier and more accurate diagnoses of hematological malignancies. The OncoChip technology assists physicians […]
TUCSON, Ariz. – HTG, Inc., provider of molecular technology solutions, today announced it has officially changed its name to HTG Molecular Diagnostics. The company, formerly known as High Throughput Genomics or HTG, made the change to convey the company’s strategic vision and direction in providing molecular testing capabilities for clinical researchers, pharmaceutical clinical development and […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
